Prosecution Insights
Last updated: April 19, 2026

Askbio Inc.

9 pending office actions

Portfolio Summary

9
Total Pending OAs
3
Final Rejections
6
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18955455 METHODS OF RECOMBINANT ADENO-ASSOCIATED VIRUS KIDNEY ADMINISTRATION SPENCE, JENNIFER SUZANNE 1633 Non-Final OA Nov 21, 2024
18027293 METHODS FOR TREATING NEUROLOGICAL DISEASE HUDSON, AMY ROSE 1636 Non-Final OA Mar 20, 2023
18019421 METHODS OF TREATING CARDIAC DISORDERS AND CONGESTIVE HEART FAILURE AND ADMINISTERING AAV VECTORS VIJAYARAGHAVAN, JAGAMYA NMN 1633 Non-Final OA Feb 02, 2023
17787900 METHOD FOR IDENTIFYING REGULATORY ELEMENTS CONFORMATIONALLY PARISI, JESSICA DANIELLE 1684 Non-Final OA Dec 06, 2022
17907229 INDUCIBLE PROMOTER FOR VIRAL VECTOR PRODUCTION HUMPHRIES, NICHOLAS ADAM 1631 Non-Final OA Sep 23, 2022
17797633 METHOD OF TREATING GENE THERAPY ASSOCIATED TOXICITY WITH ANTIBIOTICS O'NEILL, MARISOL ANN 1633 Final Rejection Aug 04, 2022
17620557 PRODUCTION OF VECTORS USING PHAGE ORIGIN OF REPLICATION HOLLAND, PAUL J 1656 Final Rejection Dec 17, 2021
17294074 THERAPEUTIC ADENO-ASSOCIATED VIRUS FOR TREATING POMPE DISEASE VIVLEMORE, TRACY ANN 1638 Final Rejection May 14, 2021
17293861 VECTORS COMPRISING A NUCLEIC ACID ENCODING LYSOSOMAL ENZYMES FUSED TO A LYSOSOMAL TARGETING SEQUENCE SALVOZA, M FRANCO G 1672 Non-Final OA May 13, 2021

Managing Askbio Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month